| Literature DB >> 35836832 |
Jun Li1, Longtao Cui1, Liping Tu1, Xiaojuan Hu2, Sihan Wang1, Yulin Shi1, Jiayi Liu1, Changle Zhou3, Yongzhi Li4, Jingbin Huang1, Jiatuo Xu1.
Abstract
Background: The prevalence of diabetes increases year by year, posing a severe threat to human health. Current treatments are difficult to prevent the progression of diabetes and its complications. It is imperative to carry out individualized treatment of diabetes, but current diagnostic methods are difficult to specify an individualized treatment plan. Objective: Clarify the distribution law of tongue features of the diabetic population, and provide the diagnostic basis for individualized treatment of traditional Chinese medicine (TCM) in the treatment of diabetes.Entities:
Year: 2022 PMID: 35836832 PMCID: PMC9276481 DOI: 10.1155/2022/7684714
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Work flow.
Dataset description.
| Class | Item | Mean ± SD/median (P25, P75) |
|---|---|---|
| Basic information | Male (%) | 357 (59%) |
| Age (years) | 58.00 (49.00, 63.00) | |
|
| ||
| Glucose and lipid metabolism | GLU (mmol/L) | 7.22 (6.05, 8.50) |
| HbA1c (%) | 6.75 (6.50, 7.40) | |
| TCHO (mmol/L) | 5.20 (4.54, 5.92) | |
| TG (mmol/L) | 1.79 (1.25, 2.61) | |
| LDL (mmol/L) | 2.91 ± 0.96 | |
| HDL (mmol/L) | 1.20 (1.03, 1.41) | |
|
| ||
| Liver function | ALT (U/L) | 23 (16, 38) |
| AST (U/L) | 21 (17, 29) | |
| GGT (U/L) | 32 (21, 51) | |
|
| ||
| Kidney function | UA (umol/L) | 338 (287, 411) |
| CREA (umol/L) | 69 (58, 80) | |
| BUN (mmol/L) | 5.19 (4.47, 6.08) | |
Note. Laboratory results included the following: (1) glucose and lipid metabolism including blood glucose (GLU), glycosylated hemoglobin (HbA1c), total cholesterol (TCHO), triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL); (2) liver function including alanine aminotransferase (ALT), aspartate transaminase (AST), and gamma-glutamyl transpeptidase (GGT); (3) kidney function including uric acid (UA), creatinine (CREA), and blood urea nitrogen (BUN).
Figure 2TFDA-1 tongue diagnosis instrument.
Figure 3Elbow diagram.
Key parameters of t-SNE.
| Parameter | Value |
|---|---|
| Perplexity | 30 |
| Early_exaggeration | 12 |
| Learning_rate | 200 |
| N_iter | 1000 |
| Min_grad_norm | 1 |
| Metric | Euclidean |
| Method | Barnes–Hut |
Figure 4Visualization of K-means clustering results based on t-SNE algorithm.
Figure 5Visualization of SOM clustering results based on t-SNE algorithm.
Figure 6Venn diagram of clustering results of K-means and SOM.
Figure 7TB-L and TC-L of K-means clustering results.
Figure 8TB-a and TC-a of K-means clustering results.
Figure 9TB-b and TC-b of K-means clustering results.
Figure 10TB-ASM and TC-ASM of K-means clustering results.
Figure 11TB-CON and TC-CON of K-means clustering results.
Figure 12TB-ENT and TC-ENT of K-means clustering results.
Figure 13TB-mean and TC-mean of K-means clustering results.
Figure 14Per-all and per-part of K-means clustering results.
Figure 15Examples of tongue images of K-means' 3 clusters. Note. To the naked eye, there are significant differences between the three types of tongue images. (a) Cluster 1 has the most delicate texture, (b) Cluster 2 has the most purple color, and (c) Cluster 3 has the roughest texture.
Figure 16Tongue feature distribution based on SOM algorithm.
Tongue feature comparation based on SOM 4 clusters.
| Item | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 |
|---|---|---|---|---|
| TB-L | 49.905 (47.923, 51.967) | 47.959 (46.683, 49.431) | 47.057 (45.501, 48.402)###▲▲▲ | 48.706 (47.468, 50.538)△□□☆☆☆ |
| TB-a | 23.918 (22.537, 25.220) | 27.014 (25.663, 28.404) | 27.660 (25.975, 28.907)###▲ | 23.780 (22.818, 25.239)□□□☆☆☆ |
| TB-b | 5.949 (4.614, 6.866) | 7.999 (7.065, 9.162) | 9.174 (8.118, 10.371)###▲▲▲ | 7.478 (6.750, 9.075)△△△☆☆☆ |
| TC-L | 53.518 (50.644, 55.435) | 51.717 (49.192, 53.752) | 46.691 (43.692, 49.318)###▲▲▲ | 51.142 (49.669, 52.920)△△△☆☆☆ |
| TC-a | 15.905 ± 1.915 | 18.518 ± 2.043 | 19.220 ± 2.189###▲▲ | 16.948 ± 1.833△△△□□□☆☆☆ |
| TC-b | 3.575 ± 2.035 | 5.304 ± 1.863 | 6.590 ± 1.854###▲▲▲ | 5.730 ± 1.811△△△☆☆☆ |
| TB-CON | 80.025 (70.801, 92.922) | 91.638 (80.664, 110.948) | 53.213 (45.052, 63.684)###▲▲▲ | 51.768 (44.479, 58.037)△△△□□□☆ |
| TB-ASM | 0.072 (0.066, 0.077) | 0.068 (0.062, 0.074) | 0.091 (0.082, 0.100)###▲▲▲ | 0.092 (0.085, 0.101)△△△□□□ |
| TB-ENT | 1.238 (1.212, 1.275) | 1.268 (1.236, 1.310) | 1.143 (1.096, 1.188)###▲▲▲ | 1.134 (1.101, 1.164)△△△□□□ |
| TB-MEAN | 0.027 (0.026, 0.029) | 0.029 (0.027, 0.032) | 0.022 (0.020, 0.024)###▲▲▲ | 0.022 (0.020, 0.023)△△△□□□ |
| TC-CON | 96.448 (82.107, 107.996) | 125.628 (109.574, 149.131) | 60.078 (48.983, 72.450)###▲▲▲ | 65.916 (55.146, 74.215)△△△□□□ |
| TC-ASM | 0.064 (0.060, 0.072) | 0.055 (0.050, 0.060) | 0.084 (0.075, 0.094)###▲▲▲ | 0.080 (0.073, 0.087)△△△□□□ |
| TC-ENT | 1.282 (1.245, 1.306) | 1.343 (1.312, 1.381) | 1.166 (1.125, 1.218)###▲▲▲ | 1.194 (1.152, 1.225)△△△□□□ |
| TC-MEAN | 0.030 (0.028, 0.032) | 0.035 (0.032, 0.037) | 0.024 (0.021, 0.026)###▲▲▲ | 0.025 (0.023, 0.027)△△△□□□ |
| Per-all | 0.456 (0.429, 0.481) | 0.341 (0.297, 0.400) | 0.303 (0.250, 0.363)###▲▲▲ | 0.422 (0.400, 0.468)△□□□☆☆☆ |
| Per-part | 1.076 (1.042, 1.132) | 1.188 (1.099, 1.363) | 1.190 (1.106, 1.338)### | 1.112 (1.044, 1.177)□□□☆☆☆ |
denotes the comparison of Cluster 1 and Cluster 2, P < 0.05, P < 0.01, and P < 0.001.# denotes the comparison of Cluster 1 and Cluster 3, #P < 0.05,##P < 0.01, and ###P < 0.001. △ denotes the comparison of Cluster 1 and Cluster 4, △P < 0.05, △△P < 0.01, and △△△P < 0.001. ▲ denotes the comparison of Cluster 2 and Cluster 3, ▲P < 0.05, ▲▲P < 0.01, and ▲▲▲P < 0.001. □ denotes the comparison of Cluster 2 and Cluster 4, □P < 0.05, □□P < 0.01, and □□□P < 0.001. ☆ denotes the comparison of Cluster 3 and Cluster 4, ☆P < 0.05, ☆☆P < 0.01, and ☆☆☆P < 0.001.
Laboratory results (K-means).
| Item | Cluster 1 ( | Cluster 2 ( | Cluster 3 ( |
|---|---|---|---|
| Gender ( | 144 (56) | 112 (65) | 86 (51) |
|
| |||
| Age (years) | 57 (49, 63) | 57 (49, 63) | 60 (52, 65)☆★ |
|
| |||
| GLU (mmol/L) | 7.300 (6.215, 8.412) | 7.480 (6.395, 9.045) | 6.845 (5.592, 8.100)☆★★ |
| ( | ( | ( | |
|
| |||
| TCHO (mmol/L) | 5.306 ± 1.106 | 5.284 ± 1.066 | 5.118 ± 1.051 |
| ( | ( | ( | |
|
| |||
| TG (mmol/L) | 1.730 (1.240, 2.420) | 1.920 (1.330, 2.960) | 1.660 (1.222, 2.468) |
| ( | ( | ( | |
|
| |||
| LDL (mmol/L) | 2.935 (2.328, 3.652) | 2.915 (2.260, 3.485) | 2.890 (2.165, 3.485) |
| ( | ( | ( | |
|
| |||
| HDL (mmol/L) | 1.185 (1.050, 1.455) | 1.190 (1.002, 1.300) | 1.230 (1.030, 1.400) |
| ( | ( | ( | |
|
| |||
| UA (umol/L) | 333.500 (280.750, 412.750) | 341.000 (288.000, 421.000) | 346.500 (293.750, 399.750) |
| ( | ( | ( | |
|
| |||
| ALT (U/L) | 23.000 (15.000, 40.000) | 24.000 (16.500, 35.500) | 24.000 (15.250, 38.000) |
| ( | ( | ( | |
|
| |||
| AST (U/L) | 21.000 (17.000, 30.000) | 21.000 (17.000, 27.000) | 21.000 (18.000, 29.000) |
| ( | ( | ( | |
|
| |||
| GGT (U/L) | 31.000 (21.000, 51.750) | 35.500 (24.250, 51.750) | 31.000 (21.000, 46.000) |
| ( | ( | ( | |
|
| |||
| TBIL (umol/L) | 12.400 (9.000, 16.200) | 13.000 (10.350, 16.775) | 11.400 (9.400, 15.500) |
| ( | ( | ( | |
|
| |||
| CREA (umol/L) | 68.500 (57.000, 80.000) | 71.000 (60.000, 80.000) | 70.000 (59.000, 80.000) |
| ( | ( | ( | |
|
| |||
| BUN (mmol/L) | 5.055 (4.400, 6.000) | 5.275 (4.500, 6.250) | 5.190 (4.600, 6.000) |
| ( | ( | ( | |
|
| |||
| eGFR (ml/min | 107.900 (92.200, 121.100) | 104.220 (92.240, 117.500) | 101.000 (86.000, 114.900) |
| ( | ( | ( | |
☆denotes the comparison of Cluster 1 and Cluster 3, ☆P < 0.05, ☆☆P < 0.01, and ☆☆☆P < 0.001. ★ denotes the comparison of Cluster 2 and Cluster 3, ★P < 0.05, ★★P < 0.01, and ★★★P < 0.001.
Laboratory results (SOM).
| Item | Cluster 1 ( | Cluster 2 ( | Cluster 3 ( | Cluster 4 ( |
|---|---|---|---|---|
| Gender ( | 82 (68) | 99 (51) | 112 (56) | 49 (60) |
|
| ||||
| Age (years) | 56 (48, 62) | 61 (54, 65) | 57 (50, 63)▲ | 54 (46, 61)□□□ |
|
| ||||
| GLU (mmol/L) | 7.565 (6.360, 9.250) | 6.900 (5.585, 8.100) | 7.200 (6.330, 8.240) | 7.810 (6.300, 9.670)□□ |
| ( | ( | ( | ( | |
|
| ||||
| TCHO (mmol/L) | 5.376 ± 1.128 | 5.061 ± 1.022 | 5.296 ± 1.084 | 5.384 ± 1.098 |
| ( | ( | ( | ( | |
|
| ||||
| TG (mmol/L) | 1.935 (1.397, 2.860) | 1.610 (1.200, 2.420) | 1.745 (1.240, 2.433) | 1.975 (1.488, 2.832) |
| ( | ( | ( | ( | |
|
| ||||
| LDL (mmol/L) | 2.960 (2.230, 3.580) | 2.790 (2.210, 3.370) | 2.940 (2.335, 3.570) | 2.990 (2.310, 3.705) |
| ( | ( | ( | ( | |
|
| ||||
| HDL (mmol/L) | 1.190 (1.025, 1.365) | 1.230 (1.020, 1.440) | 1.180 (1.048, 1.450) | 1.110 (1.025, 1.325) |
| ( | ( | ( | ( | |
|
| ||||
| UA (umol/L) | 345.(294, 419) | 337 (292, 401) | 340 (287, 412) | 326 (253, 422) |
| ( | ( | ( | ( | |
|
| ||||
| ALT (U/L) | 25 (17, 38) | 23 (16, 36) | 23 (16, 40) | 24 (15, 35) |
| ( | ( | ( | ( | |
|
| ||||
| AST (U/L) | 21 (18, 29) | 21 (18, 28) | 21 (17, 30) | 20 (17, 29) |
| ( | ( | ( | ( | |
|
| ||||
| GGT (U/L) | 36 (24, 53) | 31 (21, 44) | 31 (21, 53) | 37 (24, 57) |
| ( | ( | ( | ( | |
|
| ||||
| TBIL (umol/L) | 13 (11, 17) | 12 (9, 16) | 12 (9, 16) | 13 (9, 17) |
| ( | ( | ( | ( | |
|
| ||||
| CREA (umol/L) | 72 (61, 80) | 70 (59, 81) | 68 (56, 79) | 71 (57, 80) |
| ( | ( | ( | ( | |
|
| ||||
| BUN (mmol/L) | 5.295 (4.470, 6.455) | 5.120 (4.518, 5.975) | 5.100 (4.415, 6.000) | 5.000 (4.450, 6.100) |
| ( | ( | ( | ( | |
|
| ||||
| eGFR (ml/min | 104 (93, 117) | 102 (87, 117) | 107 (91, 122) | 103 (92, 115) |
| ( | ( | ( | ( | |
∗ denotes the comparison of Cluster 1 and Cluster 2, P < 0.05, P < 0.01, and P < 0.001. ▲ denotes the comparison of Cluster 2 and Cluster 3, ▲P < 0.05, ▲▲P < 0.01, and ▲▲▲P < 0.001. □ denotes the comparison of Cluster 2 and Cluster 4, □P < 0.05, □□P < 0.01, and □□□P < 0.001.